Relief Therapeutics Holding AG (RLF.SW)

CHF 4.1

(-6.82%)

Operating Expenses Summary of Relief Therapeutics Holding AG

  • Relief Therapeutics Holding AG's latest annual operating expenses in 2023 was 114.94 Million CHF , down -63.11% from previous year.
  • Relief Therapeutics Holding AG's latest quarterly operating expenses in 2024 Q2 was 3.14 Million CHF , down 0.0% from previous quarter.
  • Relief Therapeutics Holding AG reported a annual operating expenses of 24.52 Million CHF in annual operating expenses 2022, down -7.9% from previous year.
  • Relief Therapeutics Holding AG reported a annual operating expenses of 26.62 Million CHF in annual operating expenses 2021, up 37.96% from previous year.
  • Relief Therapeutics Holding AG reported a quarterly operating expenses of 5.92 Million CHF for 2023 Q2, down 0.0% from previous quarter.
  • Relief Therapeutics Holding AG reported a quarterly operating expenses of 9.04 Million CHF for 2023 FY, down -63.11% from previous quarter.

Annual Operating Expenses Chart of Relief Therapeutics Holding AG (2023 - 2007)

Historical Annual Operating Expenses of Relief Therapeutics Holding AG (2023 - 2007)

Year Operating Expenses Operating Expenses Growth
2023 114.94 Million CHF -63.11%
2022 24.52 Million CHF -7.9%
2021 26.62 Million CHF 37.96%
2020 19.29 Million CHF 1939.96%
2019 946 Thousand CHF 20.05%
2018 788 Thousand CHF -36.55%
2017 1.24 Million CHF -28.5%
2016 1.73 Million CHF -12.83%
2015 1.99 Million CHF -90.27%
2014 20.47 Million CHF 8.96%
2013 18.79 Million CHF 318.19%
2012 4.49 Million CHF -92.4%
2011 59.16 Million CHF 201.34%
2010 19.63 Million CHF -24.04%
2009 25.84 Million CHF 9.0%
2008 23.71 Million CHF 43.19%
2007 16.56 Million CHF 0.0%

Peer Operating Expenses Comparison of Relief Therapeutics Holding AG

Name Operating Expenses Operating Expenses Difference
Addex Therapeutics Ltd 11.89 Million CHF -866.358%
BB Biotech AG -199.56 Million CHF 157.595%
Basilea Pharmaceutica AG 111.63 Million CHF -2.961%
Evolva Holding SA 89.66 Million CHF -28.193%
Idorsia Ltd 400.38 Million CHF 71.292%
Kuros Biosciences AG 36.21 Million CHF -217.35%
Molecular Partners AG 20.3 Million CHF -466.156%
Santhera Pharmaceuticals Holding AG 31.33 Million CHF -266.813%